In this video, Dr. Brian Schwartz highlights several small-molecule TKIs in development with the potential to help patients with several malignancies.
Brian Schwartz, MD
Advertisement
Articles by Brian Schwartz, MD
Advertisement
Latest Updated Articles
Small-Molecule TKIs: Potential Benefit in Multiple MalignanciesPublished: April 26th 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves T-DXd Plus Pertuzumab in Metastatic HER2+ Breast Cancer
2
ASH 2025: The Top 10 Takeaways for Hematologic Oncology Care
3
FDA Grants National Priority Voucher to Teclistamab/Daratumumab in RRMM
4
ASH 2025: Key Discussions in Multiple Myeloma, Lymphoma, and Leukemia
5
